SCHEMBL7608310

SCHEMBL7608310

COc1ccc2[nH]c(-c3ccccc3C=O)cc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ERN1 O75460 3/20 0.37
ADORA1 P30542 2/20 0.36
ADORA2A P29274 1/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5716742 0.79 ERN1 (0.44) KDM4EALDH1A1ERN1ADORA1ADORA2A
SCHEMBL5205257 0.77 KDR (0.62) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL7066063 0.76 MEN1 (0.59) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL5716787 0.76 CLK1 (0.41) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL1788955 0.75 CYP2A6 (0.42) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL29956124 0.75 CYP2A6 (0.42) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL14431392 0.74 KDM4E (0.40) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL5716726 0.71 KDR (0.57) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL29377868 0.68 AXL (0.49) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL12614229 0.68 SIRT2 (0.46) KDM4EMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT KDM4E 2155/4885MEN1 1405/4885ALDH1A1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.